Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06831409 · ClinicalTrials.gov registry record
Using CTA Measures to Define Cardiac Risk In NFL Alumni
A clinical trial of Heart Disease and Coronary Artery Disease (CAD), sponsored by HeartFlow.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06831409: Recruiting study of Heart Disease and Coronary Artery Disease (CAD), sponsored by HeartFlow.
NCT06831409 is a study of Heart Disease and Coronary Artery Disease (CAD) that is actively recruiting participants, run by HeartFlow. The registered enrollment target is 300 participants, below the 2,037-participant average among 31 other Heart Disease trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06831409, a study of Heart Disease and Coronary Artery Disease (CAD), is actively recruiting participants, sponsored by HeartFlow.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The GAMEFILM Registry is a post-market, multi-center, data collection study assessing the presence of CAD in NFL alumni.
Primary Outcome
The proportion of participants with coronary artery disease demonstrated on coronary computed tomography angiography (CCTA).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Coronary computed tomography angiography
Study Locations (1)
Colorado
- Boone Heart Institute - Greenwood Village
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-12-17 |
| Est. Completion | 2026-12-31 |
What NCT06831409 shows while recruiting
NCT06831409 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 2,037-participant average among 31 other Heart Disease trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Coronary computed tomography angiography is the first listed.
NCT06831409 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06831409 about?
NCT06831409 is a clinical study titled "Using CTA Measures to Define Cardiac Risk In NFL Alumni". The GAMEFILM Registry is a post-market, multi-center, data collection study assessing the presence of CAD in NFL alumni.
What is the current status of trial NCT06831409?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2024-12-17. Estimated completion is 2026-12-31.
What conditions does trial NCT06831409 study?
This clinical trial studies the following conditions: Heart Disease, Coronary Artery Disease (CAD), Coronary Atherosclerosis.
What interventions are being tested in trial NCT06831409?
The interventions under investigation include: Coronary computed tomography angiography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06831409?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06831409 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06831409's enrollment target sits among peer trials
300 14th of 31 higher than 17 of 31 other Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Studies of Neuregulin/ERBB Signaling in Human Heart
RECRUITING
-
Promoting Physical Activity and Fitness Among Underserved Latino Families Living in U.S.-Mexico Border Regions
RECRUITING · NA
-
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RECRUITING · Phase 2
-
Personalized Environment and Genes Study
RECRUITING
-
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
RECRUITING · NA
-
Heart Disease of the Small Arteries in Women and Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI